Target intelligence / Profile preview

Mammalian Deoxyribonucleic Acid (DNA) (DNA)

Target
DNA
Molecular classification
Nucleic acid, Biopolymer, Genetic material, Other
01

Overview

Mammalian Deoxyribonucleic Acid (DNA) is the fundamental hereditary material located within the nucleus and mitochondria of cells, carrying the genetic instructions necessary for the development, survival, and reproduction of the organism [NIH, 2023]. It consists of two polynucleotide strands forming a double helix, which serves as the template for both its own replication and the transcription of genetic information into RNA [Wikipedia, 2024]. In clinical medicine, DNA is a critical therapeutic target, particularly for cytotoxic chemotherapy used to treat various cancers [StatPearls, 2023]. Drugs such as alkylating agents and intercalators interact directly with the DNA structure to impede replication and induce apoptosis in malignant cells [PubChem, 2024]. While highly effective at reducing tumor burden, these agents often lack cellular specificity, leading to damage in healthy, rapidly dividing tissues like the bone marrow and gastrointestinal tract [PubMed, 2022]. Consequently, the use of DNA-targeting drugs requires careful monitoring for systemic toxicities and long-term risks such as secondary cancers [NIH, 2023].

Other names
Genomic DNANuclear DNAMitochondrial DNADeoxyribonucleic acid
02

Mechanism of action

Drugs targeting mammalian DNA primarily function by inducing structural damage that inhibits essential cellular processes. This includes the formation of covalent cross-links (alkylating agents), intercalation between base pairs (anthracyclines), and the induction of single- or double-strand breaks through the inhibition of topoisomerase enzymes or direct oxidative damage [StatPearls, 2023; PubChem, 2024]. These modifications disrupt DNA replication and transcription, ultimately activating DNA damage checkpoints and triggering programmed cell death (apoptosis) in rapidly proliferating cells [NIH, 2023].

03

Biological functions

Genetic information storageDNA replicationTranscriptionInheritanceDNA repairCell cycleApoptosisCell proliferationOther
04

Disease associations

CancerAutoimmune diseaseGenetic disordersViral infectionOther
05

Safety considerations

Mutagenicity and teratogenicityMyelosuppression (bone marrow suppression)Risk of secondary malignancies (e.g., treatment-related leukemia)NephrotoxicityCardiotoxicity
06

Interacting drugs

Cisplatin

9 more in the full profile.

07

Biomarkers

gamma-H2AX (marker of double-strand breaks)Microsatellite instability (MSI)Tumor mutational burden (TMB)Circulating tumor DNA (ctDNA)8-hydroxy-2'-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Mammalian Deoxyribonucleic Acid (DNA) (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mammalian Deoxyribonucleic Acid (DNA) (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call